Display options
Share it on

Eur J Prev Cardiol. 2020 May 12;2047487320923187. doi: 10.1177/2047487320923187. Epub 2020 May 12.

Is the novel LDL-cholesterol goal <1.4 mmol/L achievable without a PCSK9 inhibitor in a chronic coronary population from clinical practice?.

European journal of preventive cardiology

John Munkhaugen, Elise Sverre, Kari Peersen, Oscar Kristiansen, Erik Gjertsen, Lars Gullestad, Jan Erik Otterstad

Affiliations

  1. Department of Medicine, Drammen Hospital, Vestre Viken Trust, Norway.
  2. Department of Behavioral Sciences in Medicine, Faculty of Medicine, University of Oslo, Norway.
  3. Department of Medicine, Vestfold Hospital Trust, Norway.
  4. Department of Cardiology, Oslo University Hospital Rikshospitalet, Faculty of Medicine, University of Oslo, Norway.
  5. KG Jebsen Center for Cardiac Research, University of Oslo, Norway.
  6. Center for Heart Failure Research, Oslo University Hospital, Norway.

PMID: 32397790 DOI: 10.1177/2047487320923187

[No abstract available.]

Publication Types